GNA11-mutated Sturge-Weber syndrome has distinct neurological and dermatological features

Eur J Neurol. 2022 Oct;29(10):3061-3070. doi: 10.1111/ene.15452. Epub 2022 Jul 13.

Abstract

Background and purpose: Sturge-Weber syndrome (SWS) is a neurocutaneous disorder characterized by clinical manifestations involving the brain, eye and skin. SWS is commonly caused by somatic mutations in G protein subunit Alpha Q (GNAQ). Five cases of subunit Alpha 11 (GNA11) mutations have been reported. We studied phenotypic features of GNA11-SWS and compared them with those of classic SWS.

Methods: Within two European multidisciplinary centers we looked for patients with clinical characteristics of SWS and a GNA11 mutation. Clinical and radiological data were collected retrospectively and prospectively.

Results: We identified three patients with SWS associated with a somatic GNA11 mutation. All had disseminated capillary malformation (CM) and hyper- or hypotrophy of an extremity. At birth, the CMs of the face, trunk and limbs were pink and patchy, and slowly darkened with age, evolving to a purple color. Two of the patients had glaucoma. All had neurological symptoms and moderate brain atrophy with a lower degree of severity than that classically associated with SWS. Susceptibility-weighted imaging (SWI) and contrast-enhanced fluid-attenuated inversion recovery (FLAIR) magnetic resonance imaging demonstrated the best sensitivity to reveal the pial angiomas.

Conclusions: We have differentiated two distinct clinical/radiological phenotypes of SWS; GNAQ- and GNA11-SWS. The classic GNAQ-SWS is characterized by a homogeneous dark-red CM, commonly associated with underlying soft tissue hypertrophy. The CM in GNA11-SWS is more reticulate and darkens with time, and the neurological picture is milder. SWI and post-contrast FLAIR sequences appear to be necessary to demonstrate leptomeningeal angiomatosis. Anti-epileptic medication or future targeted therapies may be useful, as in classic SWS.

Keywords: SWS = Sturge-Weber syndrome; hypertrophy; mutation; neurocutaneous syndrome; port-wine stain.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticonvulsants
  • Brain / diagnostic imaging
  • Brain / pathology
  • GTP-Binding Protein alpha Subunits* / genetics
  • Humans
  • Magnetic Resonance Imaging
  • Retrospective Studies
  • Sturge-Weber Syndrome* / complications
  • Sturge-Weber Syndrome* / genetics
  • Sturge-Weber Syndrome* / pathology

Substances

  • Anticonvulsants
  • GNA11 protein, human
  • GTP-Binding Protein alpha Subunits